Predicting Biotech Breakouts Before They Happen
You’re just in time for BioBoom Season: Why Fall & Winter Spark the Biggest Biotech Breakouts
Donald Trump’s influence on biotech
Trump-era policy changes had surprising effects on biotech — some accelerating innovation, others cutting research support. Read the full story »
At ScanScor.com, we’re more energized than ever by how quickly this project is evolving! Not only are we already tracking well over 15 confirmed biotech breakouts — with more lining up every week — but we’re also preparing to launch our new Advanced Reports Page with predictions and scoring system combined and while we’re giving it the thoughtful attention it deserves, the excitement is building for its debut. We’re also thrilled to see traders joining every day. FREE seats are available — and as of now, we count 88 members and growing!
🚀 Recent ScanScor Breakout Wins
Predicted in advance. No hype. No guesswork. Just AI-powered precision — 15 confirmed breakouts from our first 130 predictions (July 2025).
These results established ScanScor.com
ScanScor launched in July 2025, and full access is still FREE!
Many prediction windows remain open — and others haven’t yet begun. The next breakout could be tomorrow. Join us as we prove the power of AI predictions resulting from thorough screening and carefully crafted prompts.
Create Free AccountThe ScanScor Prediction Strategy
Step 1 — Detect Catalysts Early
Our Biomed Prediction Engine scans financials, clinical trial data, and news to uncover biotech companies preparing for breakthrough events. These are the moments when stocks often surge.
Step 2 — Define the Investment Window
Each prediction includes a clear time window and target range. This helps you know when a breakout is most likely — and how high it could go.
Step 3 — Track Results and Refine
We publish every prediction and score it after the fact. That way, you can see what worked, what didn’t, and how the system keeps getting sharper over time.
Following the ScanScor strategy is easy as 1, 2, 3
1
Review AI predictions of top biotech candidates.
2
Compare ROI, time windows, and price targets.
3
Use AI summaries, charts, and commentary to act confidently — early.
On July 1st, 2025, we screened 640 biotech companies for signals that often come before major price movement. Ranking was our first step, narrowing 640 companies to the most promising ~20% (124).
Each flag represents a measurable change in fundamentals that may indicate an emerging catalyst. Companies are ranked by how many of these indicators they’ve triggered. This process allows us to focus on the most obviously promising candidates for deeper analysis and prediction.
21,639
High R&D to Revenue Ratio14,302
Cash Runway Risk4,255
Revenue Growth Acceleration3,685
Revenue Spike ≥20%1,349
Net Income Breakout20
Upcoming Clinical Trial (Phase 2)13
Upcoming Clinical Trial (Phase 3)0
New Predictions Today
2
New Predictions This Month
135
Total Predictions
Visit regularly to view Orbo’s successful forecasts. Get a FREE ScanScor User Account to have full access to early notice of high-potential breakout candidates with approaching catalyst windows.
Recent Comments